Hypersensitivity - Modulating Factors and Immunodeficiency

Galactosylation of Immunoglobulin G and Its Role in Complement Activation Introduction Immunoglobulin G (IgG) is the most abundant antibody in the blood and carries out critical immune functions. One of these functions—activating the complement cascade—depends on modifications made to a specific region of the protein. This section explores how adding sugar residues to IgG actually enhances its ability to organize and activate complement, and then examines the surprising consequences when key immune components are missing. How Galactosylation Affects IgG Structure and Function IgG molecules contain a conserved glycan (sugar chain) attached to their Fc region—the constant part of the antibody that mediates immune functions like complement binding. When galactose residues are added to this Fc glycan through a process called galactosylation, the effect on IgG behavior is striking: these galactosylated IgG molecules become much better at clustering together to form oligomers (multiple IgG molecules linked in a complex). This oligomerization is functionally important. A single IgG molecule is largely ineffective at activating complement; however, when IgG molecules are cross-linked into larger structures through galactosylation, the Fc regions come into close proximity. This close spacing allows the Fc receptors of complement proteins—particularly C1q, the first component of the classical complement pathway—to bind much more efficiently. Think of it like the difference between scattered signposts and a dense cluster of signs: the cluster creates a strong signal that cannot be ignored. Complement Activation Through IgG Oligomers The classical complement pathway is triggered when C1q recognizes and binds to the Fc regions of antibodies attached to antigens. However, C1q requires at least two IgG Fc regions in close proximity to become activated. This requirement makes biological sense: it prevents spurious activation from a single stray antibody molecule. When galactosylation promotes IgG oligomerization, it creates exactly the geometric arrangement that C1q "expects" to see. The oligomeric IgG structures present multiple Fc regions within the small distance that C1q can bridge, leading to strong, efficient binding and activation of the complement cascade. In contrast, non-galactosylated IgG molecules—which remain more dispersed—activate complement much less efficiently. This represents an elegant regulatory mechanism: the immune system can modulate complement activation intensity not just by changing antibody quantity, but by changing the chemical modifications to antibodies already present. The Paradox of Immunodeficiency and Hypersensitivity Reactions Introduction to the Paradox One of the most counterintuitive observations in immunology is that removing parts of the immune system can sometimes increase harmful immune reactions rather than decrease them. This section explains why complement deficiency increases autoimmune disease risk, and why IgA deficiency increases celiac disease risk, despite IgA's protective role. Complement Deficiency and Systemic Lupus Erythematosus Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by autoantibodies and immune complex deposition in tissues. Remarkably, people with deficiencies of early complement pathway components (C1q, C2, or C4) have a dramatically elevated risk of developing SLE. This seems paradoxical at first: shouldn't having less complement function mean less tissue damage? The key lies in understanding what the complement system does beyond simply causing inflammation. The complement cascade serves critical housekeeping functions, including: Clearance of apoptotic cells: When cells die, they normally undergo apoptosis (programmed cell death) and are rapidly cleared by immune cells. Complement components help mark dead cells for removal. Without adequate complement, apoptotic cells accumulate and spill their contents (including intracellular proteins and DNA) into tissues. Solubilization of immune complexes: When antibodies bind antigens to form immune complexes, complement proteins coat these complexes and keep them in solution, making them easier to clear. Without complement, immune complexes precipitate and deposit in tissues. Prevention of autoimmune activation: Complement components actively suppress B cell and T cell activation through regulatory mechanisms. When complement is deficient, immune complexes persist in tissues for extended periods rather than being cleared. The body mounts immune responses against these persistent antigens and the resulting inflammation. Over time, this chronic tissue inflammation drives production of autoantibodies, perpetuating the cycle that leads to full SLE development. IgA Deficiency and Celiac Disease IgA deficiency presents an even more striking paradox. Celiac disease is a predominantly type IV hypersensitivity reaction to gluten—a disorder where the immune system recognizes gluten peptides as dangerous and mounts a T cell-mediated response in the small intestine, causing villous atrophy and malabsorption. Ironically, SLE is typically diagnosed using IgA antibodies against tissue transglutaminase (anti-tTG), which indicates that IgA plays a protective role. Yet people with IgA deficiency—complete absence of IgA antibodies—actually have a higher risk of developing celiac disease, not lower. The explanation involves IgA's protective functions: Mucosal barrier function: IgA is the predominant antibody at mucosal surfaces (including the small intestine). It normally binds potential antigens and prevents their entry across the epithelial barrier. Without IgA, foreign proteins like gluten peptides penetrate the mucosa more easily. Immune tolerance at mucosal sites: IgA helps establish tolerance to food antigens by preventing immune activation against harmless dietary proteins. Loss of IgA removes this protective suppression. Clearance of immune complexes: Like other antibody classes, IgA helps clear immune complexes from tissues. Without it, complexes persist longer and cause more inflammation. Therefore, IgA deficiency removes protective mechanisms even though IgA itself is diagnostically associated with celiac disease. General Mechanism: How Immunodeficiency Paradoxically Worsens Hypersensitivity These examples reveal a general principle: immunodeficiencies can paradoxically worsen hypersensitivity reactions and autoimmunity through several mechanisms: 1. Loss of regulatory mechanisms Components of the immune system—particularly complement—actively suppress autoreactive B and T cells. When these regulatory systems are missing, previously controlled autoimmune responses become clinically apparent. 2. Impaired clearance of antigens and complexes Many immunological mechanisms exist to remove problematic antigens and immune complexes from the body. Without them, these materials accumulate and drive repeated immune activation cycles. 3. Breakdown of tolerance at epithelial barriers IgA and other mucosal immune components prevent antigens from crossing into tissues and establish tolerance to harmless substances. Their absence allows increased antigen penetration and loss of protective tolerance. 4. Compensatory immune pathway activation When one immune pathway is deficient, other pathways may become hyperactive as the body attempts to compensate. This can lead to excessive inflammatory responses. The takeaway is fundamental: an "immunodeficiency" doesn't simply mean "weaker immunity everywhere." Rather, removing specific immune components can disrupt complex regulatory networks, leading to selective overactivity of remaining pathways—manifesting as hypersensitivity or autoimmunity rather than simple immunosuppression.